Global Measles Vaccine Market Size, by Type (MMR-II, Proquad), by Application (Children, Adults), by End User (Hospital, Vaccination Centers) & Region - Key Manufacturers, Analysis, Growth Trends, and Forecast till 2026

  • Category : Healthcare and Pharma
  • |
  • ID : 1071383
  • |
  • Publishe Date : June 2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

The Global Measles Vaccine Market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. Various initiative by the government is driving the growth of the market. However side effects like serious allergy is one of the major restraints to the market.

The global measles vaccine market is primarily segmented based on different type, application, end user and regions.

On the basis of type, the market is split into:
* Mumps Measles Rubella Vaccine
* Live (MMR-II)
* Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)

On the basis of application, the market is split into:
* Children
* Adults

On the basis of end user, the market is split into:
* Hospital
* Clinics
* Vaccination Centers

Moreover, the market is classified based on regions and countries as follows:
* North America- U.S., Canada
* Europe- U.K., France, Germany, Italy and Rest of Europe
* Asia-Pacific- China, Japan North, India and Rest of Asia Pacific
* South America- Brazil, Mexico and Rest of South America
* Middle East & Africa- South Africa, Saudi Arabia and Rest of Middle East & Africa

Key Market Players:
The key players profiled in the market include:
* MedImmune
* Johnson & Johnson Private Limited
* Merck & Co. Inc.
* Sanofi Pasteur
* Serum Institute of India Pvt. Ltd
* Bavarian Nordic
* Astellas Pharma India Private Limited
* CSL Limited
* Emergent BioSolutions Inc.
* GlaxoSmithKline plc

These enterprises are focusing on growth strategies, such as new product launches, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Key Benefits of the Report:
* Global, regional, country, type, application, end user and market size and their forecast from 2015-2026.
* Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market
* Detailed analysis on industry outlook with market specific PESTLE, and supply chain to better understand the market and build expansion strategies
* Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points
* Analysis on key players’ strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market
* Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors’ short term and long term strategies
* Detailed insights on emerging regions, type, application, end user and options with qualitative and quantitative information and fact

Target Audience:
* Measles Vaccine Manufacturers
* Traders, Importers, and Exporters
* Raw Material Suppliers and Distributors
* Research and Consulting Firms
* Government and Research Organizations
* Associations and Industry Bodies

Research Methodology:
The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data sources.
For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
* Manufacturers
* Suppliers
* Distributors
* Government Body & Associations
* Research Institutes

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global Measles Vaccine Market Overview
4.1. Market Segmentation & Scope
4.2. Market Trends
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Supply Chain Analysis
4.3. Global Measles Vaccine Market - Porter\'s Five Forces Analysis
4.4. Global Measles Vaccine Market - PESTEL Analysis

5. Global Measles Vaccine Market, by Type
5.1. Global Measles Vaccine Market, Size and Forecast, 2015-2026
5.2. Global Measles Vaccine Market by Mumps Measles Rubella Vaccine, 2015-2026
5.2.1. Key driving factors, trends and opportunities
5.2.2. Market size and forecast, 2015-2026
5.3. Global Measles Vaccine Market by Live (MMR-II), 2015-2026
5.3.1. Key driving factors, trends and opportunities
5.3.2. Market size and forecast, 2015-2026
5.4. Global Measles Vaccine Market by Mumps Measles Rubella and Varicella Virus Vaccine (Proquad), 2015-2026
5.4.1. Key driving factors, trends and opportunities
5.4.2. Market size and forecast, 2015-2026

6. Global Measles Vaccine Market, by Application
6.1. Global Measles Vaccine Market, Size and Forecast, 2015-2026
6.2. Global Measles Vaccine Market by Children, 2015-2026
6.2.1. Key driving factors, trends and opportunities
6.2.2. Market size and forecast, 2015-2026
6.3. Global Measles Vaccine Market by Adults, 2015-2026
6.3.1. Key driving factors, trends and opportunities
6.3.2. Market size and forecast, 2015-2026

7. Global Measles Vaccine Market, by End User
7.1. Global Measles Vaccine Market, Size and Forecast, 2015-2026
7.2. Global Measles Vaccine Market by Hospital, 2015-2026
7.2.1. Key driving factors, trends and opportunities
7.2.2. Market size and forecast, 2015-2026
7.3. Global Measles Vaccine Market by Clinics, 2015-2026
7.3.1. Key driving factors, trends and opportunities
7.3.2. Market size and forecast, 2015-2026
7.4. Global Measles Vaccine Market by Vaccination Centers, 2015-2026
7.4.1. Key driving factors, trends and opportunities
7.4.2. Market size and forecast, 2015-2026

8. Global Measles Vaccine Market by Region
8.1. Measles Vaccine Market Regional Analysis, 2015-2026
8.2. Global Measles Vaccine Market Revenue (USD Million) by Region, 2015-2026
8.3. North America Measles Vaccine Market, 2015-2026
8.3.1. North America Measles Vaccine Market Size and Forecast, 2015-2026
8.3.2. North America Measles Vaccine Market by Country, 2015-2026
8.3.2.1. U.S. Measles Vaccine Market, 2015-2026
8.3.2.2. Canada Measles Vaccine Market, 2015-2026
8.4. Europe Measles Vaccine Market, 2015-2026
8.4.1. Europe Measles Vaccine Market Size and Forecast, 2015-2026
8.4.2. Europe Measles Vaccine Market by Country, 2015-2026
8.4.2.1. Germany Measles Vaccine Market, 2015-2026
8.4.2.2. France Measles Vaccine Market, 2015-2026
8.4.2.3. Italy Measles Vaccine Market, 2015-2026
8.4.2.4. UK Measles Vaccine Market, 2015-2026
8.4.2.5. Spain Measles Vaccine Market, 2015-2026
8.4.2.6. Rest of Europe Measles Vaccine Market, 2015-2026
8.5. Asia Pacific Measles Vaccine Market, 2015-2026
8.5.1. Asia Pacific Measles Vaccine Market Size and Forecast, 2015-2026
8.5.2. Asia Pacific Measles Vaccine Market by Country, 2015-2026
8.5.2.1. Japan Measles Vaccine Market, 2015-2026
8.5.2.2. China Measles Vaccine Market, 2015-2026
8.5.2.3. India Measles Vaccine Market, 2015-2026
8.5.2.4. Rest of Asia Pacific Measles Vaccine Market, 2015-2026
8.6. South America Measles Vaccine Market, 2015-2026
8.6.1. South America Measles Vaccine Market Size and Forecast, 2015-2026
8.6.2. South America Measles Vaccine Market by Country, 2015-2026
8.6.2.1. Mexico Measles Vaccine Market, 2015-2026
8.6.2.2. Brazil Measles Vaccine Market, 2015-2026
8.6.2.3. Rest of South America Measles Vaccine Market, 2015-2026
8.7. Middle East & Africa Measles Vaccine Market, 2015-2026
8.7.1. Middle East & Africa Measles Vaccine Market Size and Forecast, 2015-2026
8.7.2. Middle East & Africa Measles Vaccine Market by Country, 2015-2026
8.7.2.1. Saudi Arabia Measles Vaccine Market, 2015-2026
8.7.2.2. South Africa Measles Vaccine Market, 2015-2026
8.7.2.3. Rest of Middle East & Africa Measles Vaccine Market, 2015-2026

9. Competitive Landscape
9.1. Introduction
9.2. Market Share Analysis/Top Player Positioning, 2018

10. Company Profiles
10.1. MedImmune
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Product Benchmarking
10.1.4. Key Developments
10.2. Johnson & Johnson Private Limited
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Product Benchmarking
10.2.4. Key Developments
10.3. Merck & Co. Inc.
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Product Benchmarking
10.3.4. Key Developments
10.4. Sanofi Pasteur
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Product Benchmarking
10.4.4. Key Developments
10.5. Serum Institute of India Pvt. Ltd
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Product Benchmarking
10.5.4. Key Developments
10.6. Bavarian Nordic
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Product Benchmarking
10.6.4. Key Developments
10.7. Astellas Pharma India Private Limited
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Product Benchmarking
10.7.4. Key Developments
10.8. CSL Limited
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Product Benchmarking
10.8.4. Key Developments
10.9. Emergent BioSolutions Inc.
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Product Benchmarking
10.9.4. Key Developments
10.10. GlaxoSmithKline plc
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Product Benchmarking
10.10.4. Key Developments

11. Key Insights

Content are not available

Choose License Type